Skip to content

Clinical trials

Phase 4 Heart Failure trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 4 Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20041
20062
20073
20081
20092
20151
20163
20172
20181
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Montreal Heart Institute4
Unity Health Toronto3
University of Alberta3
University of Calgary3
Abbott Medical Devices2
AstraZeneca1
Brigham and Women's Hospital1
Dinesh Thavendiranathan1
Laval University1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure22
Diabetes Mellitus, Type 23
Hypertension2
Myocardial Infarction2
Atrial Fibrillation1
Beriberi1
Cardiotoxicity1
Coronary Artery Disease1
Dementia1
Dyspnea1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.